| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/14/1992 | US5081118 Benzothiazine dioxide derivatives |
| 01/14/1992 | US5081114 Aromatase enzyme inhibitor, cancer therapy |
| 01/14/1992 | US5081112 Method for treating hyperlipidemia |
| 01/14/1992 | CA2087194A1 Targeted drug delivery via phosphonate derivatives |
| 01/14/1992 | CA2046006A1 Thioxo heterocycles |
| 01/14/1992 | CA1294281C Specific 5-ht--antagonists |
| 01/14/1992 | CA1294276C Benzothiazine dioxide derivatives |
| 01/13/1992 | WO1992000958A1 Derivatives of aspartic acid and glutamic acid having anti-cholecystokinin activity |
| 01/13/1992 | CA2087193A1 Derivatives of aspartic acid and glutamic acid having anti-cholecystokinin activity |
| 01/11/1992 | WO1992000752A1 Treatment of male infertility |
| 01/11/1992 | CA2087026A1 Treatment of male infertility |
| 01/11/1992 | CA2046495A1 Piperidine, tetrahydropyridine and pyrrolidine derivatives, their preparation process and pharmaceutical compositions thereof |
| 01/10/1992 | WO1992000995A1 Cyclic cell adhesion modulation compounds |
| 01/10/1992 | CA2087021A1 Cyclic cell adhesion modulation compounds |
| 01/09/1992 | WO1992000330A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | WO1992000329A1 Surface complexed lymphotoxin |
| 01/09/1992 | WO1992000086A1 Antitumor agent |
| 01/09/1992 | WO1992000069A1 Alteration of rate and character of hair growth |
| 01/09/1992 | WO1992000067A2 Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists |
| 01/09/1992 | WO1992000011A2 Leukotriene b4 antagonists |
| 01/09/1992 | WO1992000010A1 Method of treating human prostatic adenocarcinoma |
| 01/09/1992 | WO1991014674A3 5-lipoxygenase inhibitors |
| 01/09/1992 | CA2084510A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/08/1992 | EP0465398A2 Novel indole derivatives |
| 01/08/1992 | EP0465368A1 Sulfur derivatives of imidazole, process for their preparation, intermediates, their use as medicaments, and pharmaceutical compositions containing them |
| 01/08/1992 | EP0465343A1 Pharmaceutical or cosmetical composition comprising a retinoid and a sterol in association |
| 01/08/1992 | EP0465141A2 N-monosubstituted adamantyl/norbornanyl 17beta-carbamides of3-carboxy-androst-3,5-dienes |
| 01/08/1992 | EP0465096A1 Plasma cholesterol level lowering composition |
| 01/08/1992 | EP0464932A2 Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines |
| 01/08/1992 | EP0464845A1 Pyrrole derivatives |
| 01/08/1992 | EP0464509A1 Biphosphonic acid derivatives, their production and use |
| 01/08/1992 | EP0464137A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives |
| 01/08/1992 | EP0349535B1 New dental composition and a process for the preparation thereof |
| 01/08/1992 | EP0147461B1 11-halogene-prostane derivatives, process for obtaining them and utilization thereof as drugs |
| 01/08/1992 | CN1057649A 2,4-and 2,5-substituted pyridine-n-oxides, process for their preparation and their use |
| 01/07/1992 | US5079263 Leukocyte elastase enzyme inhibitors; controlling proteolysis |
| 01/07/1992 | US5079262 Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
| 01/07/1992 | US5079261 Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/07/1992 | US5079259 Pharmaceutically active 9-chloroprostaglandins |
| 01/07/1992 | US5079250 Tricyclic heterocyclic diols and their preparation and use |
| 01/07/1992 | US5079249 Bis(aryl)alkene pyrrolidine compounds |
| 01/07/1992 | US5079234 Inhibitors of aminoglycoside nephrotoxicity |
| 01/03/1992 | WO1992000076A1 Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol |
| 01/02/1992 | EP0463810A1 Heterocyclic compound and psychopharmaceutical composition containing same |
| 01/02/1992 | EP0463592A1 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and for their utilization |
| 01/02/1992 | EP0463139A1 2,13-disubstituted ergolins, their preparation and their use in drugs. |
| 01/02/1992 | EP0463123A1 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism |
| 01/02/1992 | EP0463037A1 Human macrophage migration inhibitory factor |
| 01/02/1992 | EP0463004A1 Metabolic effects of leukaemia inhibitory factor on bone |
| 01/02/1992 | EP0462964A1 Treatment of skin diseases and tumors |
| 01/02/1992 | EP0439513A4 Composition for inhibiting transmission of aids |
| 01/02/1992 | EP0425565A4 Silicon compounds in bone treatment |
| 01/02/1992 | EP0309541B1 Sulfonylcarboxamides |
| 01/01/1992 | CN1015264B Process for preparing orally active phosphonyl hydroxyacyl prolines |
| 01/01/1992 | CN1015259B Preparation of perhydrothiazepine derivative |
| 12/31/1991 | US5077397 Sialic acid derivative with active ester groups |
| 12/31/1991 | US5077302 Urea derivatives |
| 12/31/1991 | US5077301 Side-effect inhibition |
| 12/31/1991 | US5077298 Administering neuroleptic agents |
| 12/31/1991 | US5077292 (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 12/31/1991 | US5077288 Adrenergic, serotonin and histamine antagonist |
| 12/31/1991 | US5077276 Growth factor |
| 12/31/1991 | CA1293839C Process for obtention of peptide amino-alcohol derivatives containing a tetrasubstituted carbon as inhibiting agents of renin and acid proteases |
| 12/31/1991 | CA1293727C 9-deazaguanines |
| 12/31/1991 | CA1293717C Low molecular alkali huminates, process of producing same and their use |
| 12/29/1991 | WO1992000279A1 Chemical compounds |
| 12/29/1991 | WO1992000068A1 Substituted histidines |
| 12/29/1991 | CA2084776A1 Substituted histidines |
| 12/29/1991 | CA2083710A1 Quinolinyl substituted phenyl/thioalkanoic acid substituted propionic acids |
| 12/29/1991 | CA2045868A1 2,4- and 2,5-substituted pyridine-n-oxides, processes for their preparation and their use |
| 12/29/1991 | CA2045867A1 N-monosubstituted adamantyl/norbornanyl 17_beta-carbamides of 3-carboxy-androsts-3,5-dienes as testosterone 5 alpha-reductase inhibitors |
| 12/27/1991 | EP0462813A2 Bicyclic pyran derivatives and their use as inhibitors of 5-lipoxygenase |
| 12/27/1991 | EP0462812A2 Pyran derivatives as inhibitors of 5-lipoxygenase |
| 12/27/1991 | EP0462800A2 Inhibitors of HIV reverse transcriptase |
| 12/27/1991 | EP0462696A1 Novel pyrido [2,3-f][1,4] thiazepines and pyrido [3,2-b][1,5] benzothiazepines |
| 12/27/1991 | EP0462668A2 New 17beta-aminobenzoyl-4-aza-5alpha-androst-1-en-3-ones as benign prostatic hypertrophy agents |
| 12/27/1991 | EP0462667A2 Beta-lactams as antihypercholesterolemics |
| 12/27/1991 | EP0462665A2 Selected 17beta-polyaroyl-4-aza-5alpha-androst-1-en-3-ones as steroidal reductase inhibitors |
| 12/27/1991 | EP0462664A2 Specific 17beta-thiobenzoyl-4-aza-5alpha-androst-1-en-3-ones as antiandrogenic agents |
| 12/27/1991 | EP0462662A2 17beta-N-monosubstituted adamantyl/norbornanyl carbamoyl-4-aza-5alpha-androst-1-en-3-ones and androstan-3-ones |
| 12/27/1991 | EP0462661A2 Novel 17beta-hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones as testosterone reductase inhibitors |
| 12/27/1991 | EP0462549A1 Process of preparing a therapeutic agent for renal diseases |
| 12/27/1991 | EP0462264A1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications as paf-antagonists. |
| 12/27/1991 | EP0462177A1 Purified insulin mediators and purification process for same |
| 12/27/1991 | CA2045428A1 Method for enhancing the lowering of plasma cholesterol levels |
| 12/26/1991 | WO1991019978A1 Using 5,10,15,20-tetrakis(4-carboxyphenyl)porphine for detecting and treating lung cancers |
| 12/26/1991 | WO1991019977A1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER |
| 12/26/1991 | WO1991019787A1 Protease nexin-i variants |
| 12/26/1991 | WO1991019510A1 Osteoinductive pharmaceutical formulations |
| 12/26/1991 | CA2085980A1 Protease nexin-i variants |
| 12/26/1991 | CA2045293A1 Bisphosphonic acid derivatives, their production and use |
| 12/25/1991 | WO1992000296A1 Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
| 12/25/1991 | CN1057268A Crystalline interleukin-4 |
| 12/25/1991 | CN1057262A Cyclic amide derivatives |
| 12/25/1991 | CA2084288A1 Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
| 12/24/1991 | US5075440 Hypotensive, bronchodilator agents |
| 12/24/1991 | US5075335 Enzyme inhibitors |
| 12/24/1991 | US5075329 Blocking toxic effects of oxygen free radicals |
| 12/24/1991 | US5075322 Antiallergens |
| 12/24/1991 | US5075310 Pyrimidone derivatives as bronchodilators |